Heart failure with midrange ejection fraction: Prior left ventricular ejection fraction and prognosis [PDF]
Evidence-based guidelines for heart failure management depend mainly on current left ventricular ejection fraction (LVEF). However, fewer studies have examined the impact of prior LVEF. Patients may enter the heart failure with midrange ejection fraction
Zhang, Yanli +8 more
core +1 more source
Reverse atrial remodeling in heart failure with recovered ejection fraction [PDF]
Background Heart failure with recovered ejection fraction (HFrecEF) has been a newly recognized entity since 2020. However, the concept has primarily focused on left ventricular ejection fraction improvement, with less focus on the recovery of the left ...
Yunlong Xia +9 more
core +1 more source
Efficacy of guideline-directed medical treatment in heart failure with mildly reduced ejection fraction. [PDF]
Heart failure with mildly reduced ejection fraction (HFmrEF) has received increasing attention following the publication of the latest ESC guidelines in 2021.
Zhang, Yunlong +10 more
core +1 more source
Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction [PDF]
Aims There is an emerging interest in elucidating the natural history and prognosis for patients with heart failure with reduced ejection fraction (HFrEF) in whom left ventricular ejection fraction (LVEF) subsequently improves.
Zhang, Yanli +11 more
core +1 more source
Exercise training in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis [PDF]
Background While exercise training (ET) is an established tool in heart failure (HF), no research to date has analysed the efficacy of ET in both preserved (HFpEF) and reduced (HFrEF) ejection fraction phenotypes across the same clinically important ...
O'Driscoll, J., Edwards, J.
core +1 more source
Recent studies have shown that circulating levels of irisin are prognostic factors in heart failure (HF), but no data are available on the predictive role of irisin in patients with type 2 diabetes mellitus (T2DM) and different phenotypes of HF.
Alexander A. Berezin +4 more
doaj +1 more source
Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved ...
Valeria Conti +14 more
doaj +1 more source
The value of IGF-1 and IGFBP-1 in patients with heart failure with reduced, mid-range, and preserved ejection fraction [PDF]
Background: Previous studies have reported inconsistent results regarding the implications of deranged insulin-like growth factor 1 (IGF-1)/insulin-like growth factor-binding protein 1 (IGFBP-1) axis in patients with heart failure (HF).
Tse, Gary +5 more
core +1 more source
Currently, the assessment of left ventricular ejection fraction (LVEF) is the cornerstone of the classification of patients with heart failure (HF). The mid‐range LVEF (HFmrEF) category was identified in an attempt to uncover specific characteristics of ...
Luca Branca +3 more
doaj +1 more source
Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction
The findings of randomized trials of neurohormonal modulation have been neutral in heart failure with preserved ejection fraction and consistently positive in heart failure with reduced ejection.
Rohan Samson, Thierry H. Le Jemtel
doaj +1 more source

